N末端脑钠肽前体是系统性红斑狼疮心血管损伤的生物标志物:一项横断面研究
在270例未选择的系统性红斑狼疮(SLE)患者中,33例(12%)存在心血管损伤(CVD)。NT-proBNP与CVD强相关(AUC 0.78,95%CI 0.69-0.87),阈值133 pg/ml区分最佳;多变量模型中NT-proBNP>133 pg/ml与CVD相关(OR 7.0,95%CI 2.6-19.1)。NT-proBNP升高与年龄、曾吸烟、eGFR降低、既往心包炎/胸膜炎及aPL抗体相关。
要点
- SLE患者中NT-proBNP与SLICC损伤指数定义的心血管损伤强相关,AUC 0.78。
- NT-proBNP>133 pg/ml与CVD独立相关(OR 7.0,95%CI 2.6-19.1)。
- NT-proBNP升高与既往心包炎/胸膜炎及aPL抗体相关,提示新研究方向。
核心结论
- NT-proBNP是SLE中心血管损伤的生物标志物。
- NT-proBNP水平与既往心包炎/胸膜炎及aPL抗体的新关联为理解SLE心血管风险驱动因素提供了新研究方向。
研究设计与样本
- 横断面研究,纳入MUHC狼疮门诊注册的未选择SLE患者,血清采集于2022年3月至2023年4月的年度研究访视。
- 共270例SLE患者纳入主要结局分析,女性91%,中位年龄50.7岁(四分位距39.6-62.1)。
主要发现
- 270例中33例(12%)存在SLICC损伤指数定义的心血管损伤。
- NT-proBNP的ROC曲线与CVD强相关,AUC 0.78(95%CI 0.69-0.87),阈值133 pg/ml区分最佳。
- 多变量logistic回归中,高血压(OR 3.3,95%CI 1.2-9.0)、血脂异常(OR 3.6,95%CI 1.3-9.6)和NT-proBNP>133 pg/ml(OR 7.0,95%CI 2.6-19.1)与CVD相关。
- NT-proBNP水平升高与年龄(OR 4.2,95%CI 2.2-8.3)、曾吸烟(OR 1.9,95%CI 1.0-3.5)、eGFR降低(OR 4.1,95%CI 1.3-13.1)、既往心包炎/胸膜炎(OR 2.5,95%CI 1.4-4.5)及aPL抗体(OR 2.6,95%CI 1.4-4.9)相关。
关键数值与推荐
- NT-proBNP阈值133 pg/ml对CVD区分最佳(AUC 0.78,95%CI 0.69-0.87)。
- NT-proBNP>133 pg/ml与CVD的OR 7.0(95%CI 2.6-19.1)。
- 高血压与CVD的OR 3.3(95%CI 1.2-9.0),血脂异常与CVD的OR 3.6(95%CI 1.3-9.6)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Prediction models based on traditional risk factors underestimate cardiovascular (CV) risk in systemic lupus erythematosus (SLE). In a large sample of unselected SLE patients, we investigated cross-sectional associations of NT-proBNP with cardiovascular damage (CVD). METHODS: Serum NT-proBNP was measured in SLE patients enrolled in the MUHC Lupus Clinic registry. Serum was collected between March 2022 and April 2023 at annual research visits. The primary outcome was CVD identified on the SLICC Damage Index. Factors associated with CVD and NT-proBNP levels were determined. RESULTS: Overall, 270 SLE patients [female 91%, median age 50.7 (first quartile to third quartile: 39.6-62.1) years] were analysed for the primary outcome. Among them, 33 (12%) had CVD. The ROC curve for NT-proBNP demonstrated strong associations with CVD (AUC 0.78, 95% CI 0.69-0.87) with a threshold of 133 pg/ml providing the best discrimination for those with/without CVD. Hypertension (OR 3.3, 95% CI 1.2-9.0), dyslipidaemia (OR 3.6, 95% CI 1.3-9.6) and NT-proBNP >133 pg/ml (OR 7.0, 95% CI, 2.6-19.1) were associated with CVD in the multivariable logistic regression model. Increased NT-proBNP levels were associated with age (OR 4.2, 95% CI 2.2-8.3), ever smoking (OR 1.9, 95% CI 1.0-3.5), reduced eGFR (4.1, 95% CI 1.3-13.1), prior pericarditis/pleuritis (OR 2.5, 95% CI 1.4-4.5) and aPL antibodies (OR 2.6, 95% CI 1.4-4.9). CONCLUSION: NT-proBNP is a biomarker for CV damage in SLE. The novel associations of NT-proBNP levels with prior pericarditis/pleuritis and aPL antibodies suggest new avenues for research to better understand what drives CV risk in SLE.
引用
- Sacre K, Vinet E, Pineau CA, et al. N-terminal pro-brain natriuretic peptide is a biomarker for cardiovascular damage in systemic lupus erythematous: a cross-sectional study. Rheumatology (Oxford). 2024. PMID: 37802912. doi:10.1093/rheumatology/kead522
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。